Dr. Sulaiman Al Habib Medical Services Group Company Financials

Market Capitalization SR106.68 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	47.36
Forward PE	40.11
Price to Sales TTM	SR10.10
Price to Book MRQ	SR15.08
Enterprise to Revenue	10.49
Enterprise to EBITDA	42.89

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	21.09%
Operating Margin	20.98%
Return on Assets TTM	8.25%
Return on Equity TTM	32.47%

Income Statement

Revenue TTM	SR10,558,075,904
Revenue per Share TTM	SR30.17
Quarterly Revenue Growth	21.90%
Gross Profit TTM	SR3,270,048,068
EBITDA	SR2,778,091,017
Net Income to Common TTM	SR2,226,527,232
Diluted EPS TTM	SR6.36
Quarterly Earnings Growth YoY	9.30%

Balance Sheet

Total Cash MRQ	SR2,375,899,648
Total Cash per Share MRQ	SR6.79
Total Debt MRQ	SR
Total Debt to Equity MRQ	98.12
Current Ratio MRQ	1.22
Book Value per Share MRQ	SR19.97

Cash Flow

Operating Cash Flow TTM	SR3,058,128,384
Levered Free Cash Flow TTM	SR-1,733,753,600

4013 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	350,000,000
Float Shares	101,804,500
Avg 10 Volume	263,786
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	68.80%
% Held by Institutions	3.39%

Stock Price Summary

Beta	0.66
Fifty Two Week Low	SR258.00
Fifty Two Week High	SR346.80
Fifty Two Week Change	-1.23%
Day 50 MA	SR283.26
Day 200 MA	SR296.51

Dividends and Splits

Forward Annual Dividend Rate	SR4.80
Forward Annual Dividend Yield	1.64%
Trailing Annual Dividend Rate	SR4.69
Trailing Annual Dividend Yield	1.61%
Payout Ratio	73.27%
Dividend Date
Ex Dividend Date	2024-11-10
Last Split Factor
Last Split Date